BusinessChromaDex Announces Reverse Stock Split as Company Seeks to List its Common Stock on The NASDAQ Capital MarketBy Nasdaq OMXApr 12, 2016, 8:05 PM UTC
BusinessProject HOPE with Support from Eli Lilly and Company Makes Strides against Diabetes and Hypertension in IndiaBy Nasdaq OMXApr 6, 2016, 2:35 PM UTC
BusinessEarth Science Tech Announces 3 New Marketing and Distribution Agreements for its ETST High Grade Hemp CBD (Cannabidiol) Oil Products and Welcomes Mr. Gabriel Aviles as its Nutritional Educator elected to Company’s Advisory BoardBy Nasdaq OMXMar 22, 2016, 12:45 PM UTC
BusinessChromaDex Reports 2015 Record Revenue as Ingredient Sales Grew 83%By Nasdaq OMXMar 17, 2016, 8:44 PM UTC
BusinessChromaDex Initiates Second Human Clinical Study on NIAGEN® -The World’s First and Only Commercially Available Form of Nicotinamide Riboside (NR)By Nasdaq OMXMar 10, 2016, 11:30 AM UTC
BusinessCan Mindful Eating Help Lower Risk of Type 2 Diabetes and Cardiovascular Disease?By Nasdaq OMXMar 9, 2016, 1:11 PM UTC
BusinessChromaDex to Present at the 28th Annual ROTH Conference on March 15, 2016By Nasdaq OMXMar 1, 2016, 11:30 AM UTC
